TuHURA Biosciences (HURA) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citizens | Maintained | Market Outperform | $9.00 | Aug 18, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $9.00 | Apr 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Feb 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $12.00 | Jan 9, 2026 |
| Maxim Group | Maintained | Buy | $8.00 from $15.00 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | May 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $13.00 | Apr 3, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $13.00 | Mar 3, 2025 |
| Rodman & Renshaw | Initiated Coverage | Buy | $11.00 | Dec 19, 2024 |
| Maxim Group | Upgraded | Hold → Buy | $14.00 | Jul 14, 2023 |
Frequently asked questions
Is HURA a buy, sell, or hold?
Analysts covering TuHURA Biosciences currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on HURA?
On Aug 18, 2026, Citizens maintained TuHURA Biosciences at Market Outperform with a price target of $9.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.